Activity of non-fluorinated quinolones (NFQs) against quinolone-resistant Escherichia coli and Streptococcus pneumoniae

Journal of Antimicrobial Chemotherapy

Volumn 48, Issue 1, 2001, Pages 29-36

  Roychoudhury, S ^a   Twinem, T L ^a   Makin, K M ^a   McIntosh, E J ^a   Ledoussal, B ^a   Catrenich, C E ^a  

^a PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZITHROMYCIN; BACTERIAL ENZYME; CIPROFLOXACIN; CLINAFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING); GATIFLOXACIN; PENICILLIN G; PGE 4175997; PGE 9262932; PGE 9509924; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SERINE; TROVAFLOXACIN; TRYPTOPHAN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; ASSAY; BACTERIUM ISOLATE; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; DRUG POTENCY; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; ESCHERICHIA COLI; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; MUTANT; NONHUMAN; PENICILLIN RESISTANCE; STREPTOCOCCUS PNEUMONIAE;

EID: 0034919207     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/48.1.29     Document Type: Article

References (23)

1. Mechanisms of fluoroquinolone resistance: An update 1994-1998
2. Emerging resistance problems among respiratory tract pathogens
3. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network
4. The ECO.SENS project: A prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens-interim report
5. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998
6. 4-Quinolone resistance mutations in the DNA gyrase of Escherichia coli clinical isolates identified by using the polymerase chain reaction
7. Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates
8. Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae: Contributions of type II topoisomerase mutations and efflux to levels of resistance
9. In vitro activities of 3 non-fluorinated quinolones and 3 fluoroquinolones against consecutive clinical isolates from eleven U.S. medical centers
10. Quinolone resistance in staphylococci: Activities of new nonfluorinated quinolones against molecular targets in whole cells and clinical isolates
11. Characterization of fluoroquinolone-resistant mutants of Escherichia coli selected in vitro
12. Isolation of fluoroquinolone-resistant Escherichia coli and Klebsiella pneumoniae from an infected Hickman catheter
13. Detection of mutations on parC in quinolone-resistant clinical isolates of Escherichia coli
14. Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitro
15. Contribution of mutations in gyrA and parC genes to fluoroquinolone resistance of mutants of Streptococcus pneumoniae obtained in vivo and in vitro
16. Therapeutic failure and selection of resistance to quinolones in a case of pneumococcal pneumonia treated with ciprofloxacin
17. Cloning of the DNA gyrase genes under tac promoter control: Overproduction of the gyrase A and B proteins
18. A single point mutation in the DNA gyrase protein A greatly reduces binding of fluoroquinolones to the gyrase-DNA complex
19. Testing potential gyrase inhibitors of bacterial DNA gyrase: A comparison of the supercoiling inhibition assay and "cleavable complex" assay
20. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically-Fourth Edition: Approved Standard M7-A4
21. Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: Selective targeting of gyrase or topoisomerase IV by quinolones
22. Primary targets of fluoroquinolones in Streptococcus pneumoniae
23. DNA gyrase and topoisomerase IV are dual targets of clinafloxacin action in Streptococcus pneumoniae